Clinical Trials Browser

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell

NCT06172478 2026-05-15

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 2 Recruiting

740 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07586813 2026-05-14

N01-A-PICIT-GI

Phase 2 Recruiting

220 enrolled

Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT04550494 2026-05-13

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Phase 2 Recruiting

36 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT06760819 2026-05-07

panSOHO

Phase 2 Recruiting

111 enrolled

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors

NCT06941857 2026-05-05

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Phase 2 Recruiting

20 enrolled

Gastrointestinal

Carcinoma, Pancreatic Neoplasms

NCT07354919 2026-05-05

AxeCan

Phase 2 Recruiting

34 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06050317 2026-05-01

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07255404 2026-04-29

A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Phase 2 Recruiting

105 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06423326 2026-04-22

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Phase 2 Recruiting

36 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07450859 2026-04-22

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 2 Recruiting

39 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT07542002 2026-04-21

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Phase 2 Recruiting

37 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04074135 2026-04-20

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

740 enrolled

EndocrineGastrointestinalNET

von Hippel-Lindau Disease, Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT05065801 2026-04-15

GABRINOX2

Phase 2 Recruiting

162 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT07126158 2026-04-15

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

Phase 2 Recruiting

36 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06695845 2026-04-09

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Phase 2 Recruiting

200 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06850623 2026-04-03

ENACT

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT07504471 2026-03-31

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Phase 2 Recruiting

50 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06756074 2026-03-16

Reinforced Pancreaticojejunostomy With or Without glubran2

Phase 2 Recruiting

100 enrolled

Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

NCT06008288 2026-03-13

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

Phase 2 Recruiting

88 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04683315 2026-03-05

PANCREAS

Phase 2 Recruiting

84 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07072728 2026-03-03

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Phase 2 Recruiting

87 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Adjustment Disorders, Breast Neoplasms, Kidney Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07114315 2026-03-03

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Phase 2 Recruiting

160 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04485286 2026-02-27

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Phase 2 Recruiting

72 enrolled

GastrointestinalThoracic

Radiation Fibrosis Syndrome, Fibrosis, Lung Neoplasms, Pancreatic Neoplasms

NCT07006077 2026-02-27

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

Phase 2 Recruiting

12 enrolled

Gastrointestinal

Pancreatic Neoplasms, Vaccinia

NCT06906562 2026-02-17

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04115163 2026-02-11

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Phase 2 Recruiting

67 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06662006 2026-02-06

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Phase 2 Recruiting

56 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Phase 2 Recruiting

78 enrolled

Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

NCT06381154 2026-01-30

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06951997 2026-01-26

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Phase 2 Recruiting

33 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03977233 2026-01-13

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Phase 2 Recruiting

45 enrolled

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT03322995 2026-01-08

PANC

Phase 2 Recruiting

125 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06547736 2026-01-05

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Phase 2 Recruiting

160 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07226856 2025-12-22

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Phase 2 Recruiting

43 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04858009 2025-12-16

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06584227 2025-12-08

ACPC

Phase 2 Recruiting

45 enrolled

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT07269626 2025-12-08

PULSAR in Systemic Therapy for Pancreatic Cancer

Phase 2 Recruiting

47 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04753879 2025-12-04

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Phase 2 Recruiting

38 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07230509 2025-12-02

NBCA

Phase 2 Recruiting

90 enrolled

Gastrointestinal

Pancreatic Neoplasms, Anastomotic Leak

NCT07257523 2025-12-02

Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer

Phase 2 Recruiting

33 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07043270 2025-10-20

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Phase 2 Recruiting

35 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03915678 2025-10-06

AGADIR

Phase 2 Recruiting

247 enrolled

BreastDermatologicGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT03492671 2025-10-02

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05518903 2025-10-02

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Phase 2 Recruiting

130 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06770452 2025-09-23

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Phase 2 Recruiting

32 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

N01-A-PICIT-GI

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

panSOHO

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

AxeCan

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

GABRINOX2

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

ENACT

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Reinforced Pancreaticojejunostomy With or Without glubran2

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

PANCREAS

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

PANC

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

ACPC

PULSAR in Systemic Therapy for Pancreatic Cancer

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

NBCA

Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

AGADIR

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients